Sugi Predict

Sugi Predict / Compounds / SCHEMBL289780

SCHEMBL289780

SCHEMBL289780

O=C(O)Cc1cccc(I)c1CC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 3/20 0.50
▸ TDP1 Q9NUW8 2/20 0.48
▸ DUSP3 P51452 1/20 0.47
▸ PTPN5 P54829 1/20 0.47
▸ PTPN11 Q06124 1/20 0.47
▸ CTDSP1 Q9GZU7 1/20 0.47
▸ CYP1A2 P05177 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ GRIN2D O15399 1/20 0.42
▸ GRIN3B O60391 1/20 0.42
▸ GRIN1 Q05586 1/20 0.42
▸ GRIN2A Q12879 1/20 0.42
▸ GRIN2B Q13224 1/20 0.42
▸ GRIN2C Q14957 1/20 0.42
▸ GRIN3A Q8TCU5 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ PTGS2 P35354 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL5540371 0.94 AKR1B1 (0.46) AKR1B1TDP1DUSP3PTPN5PTPN11
SCHEMBL29101379 0.89 AKR1B1 (0.46) AKR1B1TDP1DUSP3PTPN5PTPN11
Iodobenzene SCHEMBL31189210 0.88 AKR1B1 (0.44) AKR1B1TDP1DUSP3PTPN5PTPN11
SCHEMBL5543109 0.88 AKR1B1 (0.41) AKR1B1TDP1DUSP3PTPN5PTPN11
SCHEMBL29744505 0.87 AKR1B1 (0.40) AKR1B1TDP1DUSP3PTPN5PTPN11
Benzene SCHEMBL1146112 0.85 AKR1B1 (0.60) AKR1B1TDP1DUSP3PTPN5PTPN11
SCHEMBL1873283 0.85 AKR1B1 (0.60) AKR1B1TDP1DUSP3PTPN5PTPN11
SCHEMBL1701028 0.82 AKR1B1 (0.42) AKR1B1TDP1DUSP3PTPN5PTPN11
Acetic Acid SCHEMBL5543107 0.81 AKR1B1 (0.37) AKR1B1TDP1DUSP3PTPN5PTPN11
SCHEMBL314806 0.81 AKR1B1 (0.61) AKR1B1TDP1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 583 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12623993-B2 Synthesis of vinyl cyclobutyl intermediates AMGEN INC. (US) 2026-05-12 — — US claimed
CN-119504503-A Method for efficiently preparing Fmoc-Dap-OH 成都市科隆化学品有限公司 2025-02-25 — — CN claimed
US-20230183164-A1 Synthesis of Vinyl Cyclobutyl Intermediates AMGEN INC. (US) 2023-06-15 — — US claimed
US-20230136910-A1 Synthesis of vinylic alcohol intermediates AMGEN INC. (US) 2023-05-04 — — US claimed
EP-4146637-A1 SYNTHESIS OF VINYLIC ALCOHOL INTERMEDIATES Amgen Inc. (US) 2023-03-15 — — EP claimed
EP-4146634-A1 SYNTHESIS OF VINYL CYCLOBUTYL INTERMEDIATES Amgen Inc. (US) 2023-03-15 — — EP claimed
WO-2022267945-A1 METHOD FOR PREPARING PRANOPROFEN AND COMPOSITION CONTAINING PRANOPROFEN AND IMPURITY 沈阳兴齐眼药股份有限公司 2022-12-29 — — WO claimed
US-11345688-B2 Compound, preparing method therefor, and organic light emitting element comprising same DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2022-05-31 — — US claimed
WO-2021225835-A1 SYNTHESIS OF VINYLIC ALCOHOL INTERMEDIATES AMGEN INC. (US) 2021-11-11 — — WO claimed
WO-2021226009-A1 SYNTHESIS OF VINYL CYCLOBUTYL INTERMEDIATES AMGEN INC. (US) 2021-11-11 — — WO claimed
WO-2003082895-A2 PROCESS TO PREPARE EPLERENONE PHARMACIA & UPJOHN COMPANY (US) 2003-10-09 — — WO claimed
EP-1042314-B1 METHOD OF PREPARING ENANTIOMERICALLY-ENRICHED TETRAHYDROBENZOTHIEPINE OXIDES SEARLE & CO (US) 2003-03-19 — — EP claimed
EP-0547165-B1 Process for the Preparation of Water-Soluble Camptothecin Analogues, as well as the compounds 10-Hydroxy-11-C(1-6)-alkoxycamptothecin SMITHKLINE BEECHAM CORP (US) 1999-11-10 — — EP claimed
US-5734056-A Process for the preparation of certain 9-substituted camptothecins SMITHKLINE BEECHAM CORPORATION (US) 1998-03-31 — — US claimed
US-5594158-A Processes for producing doxorubicin, daunomycinone, and derivatives of doxorubicin THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 1997-01-14 — — US claimed
EP-0547165-A4 — — 1994-03-30 — — EP claimed
EP-0547165-A1 WATER SOLUBLE CAMPTOTHECIN ANALOGUES, PROCESSES AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 1993-06-23 — — EP claimed
US-5200513-A Processes for producing doxorubicin, daunomycinone, and derivatives of doxorubicin BOARD OF REGENTS, UNIVERSITY OF NEBRASKA-LINCOLN (US) 1993-04-06 — — US claimed
EP-0523289-A1 Processes for producing doxorubicin, daunomycinone, and derivatives of doxorubicin Board of Regents of the University of Nebraska (US) 1993-01-20 — — EP claimed
WO-1992005785-A1 WATER SOLUBLE CAMPTOTHECIN ANALOGUES, PROCESSES AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 1992-04-16 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183164-A1 Synthesis of Vinyl Cyclobutyl Intermediates MCL1, BCL2A1, BAK1 AKR1B1 1074/4885TDP1 2603/4885DUSP3 3933/4885
US-20230136910-A1 Synthesis of vinylic alcohol intermediates MCL1, BCL2A1, BAK1 AKR1B1 142/4885TDP1 1306/4885DUSP3 2752/4885
US-12623993-B2 Synthesis of vinyl cyclobutyl intermediates MCL1, BCL2, BCL2L1 AKR1B1 118/4885TDP1 3521/4885DUSP3 1341/4885
US-11345688-B2 Compound, preparing method therefor, and organic light emitting element comprising same CYP4F11, CYP4A11, WEE2 AKR1B1 619/4885TDP1 4379/4885DUSP3 4866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.